Related Experiment Video
Updated: Jun 9, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Neuroendocrine Carcinoma of the Bladder
Takashi Kawahara1, Shoji Yamanaka, Hisashi Ohshiro
1Department of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Abstract:
The case was a 67-year-old male who visited our hospital with a major complaint of macroscopic hematuria. A bladder tumor was found. When a transurethral resection of the bladder tumor was performed, the histopathological diagnosis was neuroendocrine bladder cancer. After chemotherapy with cisplatin and etoposide a partial shrinkage of the tumor was observed; however, the patient expired 7 months after the first visit.
